Application of artificial intelligence in multiple sclerosis research

VernacularTitle:人工智能在多发性硬化研究中的应用
Author: Chunxin LIU ; Wenjing LUO ; Wei QIU
From: Chinese Journal of Neurology 2021;54(3):281-284
CountryChina
Language:Chinese
Abstract: Multiple sclerosis (MS) is a demyelinating autoimmune disease of the central nervous system. It mainly occurs in young and middle-aged people and has a high disability rate. The pathogenesis of MS has not been fully elucidated, with great genetic heterogeneity, diverse clinical phenotypes, lack of specific biomarkers, numerous and complicated research data, which bring great challenges to the diagnosis and treatment of MS. Artificial intelligence (AI), as the cutting-edge hotspot in the development of science and technology, is widely used in the medical field to assist in the diagnosis, treatment and prognosis of various diseases. Its infinite learning ability greatly promotes the management of MS. This article will review the application of AI in MS diagnosis and treatment.